Archive

Every story we've published. Filter by category and date.

4509 articles · page 41 of 188

Summit Therapeutics stock: update

PremiumBreakingSMMTJun 14, 20261 min read

OTLK: stock update

PremiumBreakingOTLKJun 14, 20261 min read

The United States government makes a dramatic decision

BreakingJun 14, 20261 min read

Market update: Iran, Japan, and the Fed

PremiumMarket OverviewJun 14, 20261 min read

SpaceX's historic IPO hides thousands of stories of ordinary people

DeepdivesSPCXJun 14, 20261 min read

Iran denies agreement with the US: confusion in the markets

BreakingJun 13, 20261 min read

Trump: agreement with Iran for signing tomorrow, Strait of Hormuz will open

BreakingJun 13, 20261 min read

Meet Kinsale Group

PremiumInsidersKNSLJun 12, 20262 min read

Trading open: SPCX at $170

BreakingSPCXJun 12, 20261 min read

SpaceX shares indicate an open 29% above the IPO price

BreakingSPCXJun 12, 20261 min read

Cerebras: analysts are unanimous

PremiumAnalystsCBRSJun 12, 20261 min read

Dramatic report: US-Iran agreement on Sunday?

BreakingJun 12, 20261 min read

What is happening at Pagaya?

PremiumInsidersPGYJun 12, 20262 min read

Mega IPOs: the impact on liquidity and the S&P 500

Market OverviewJun 12, 20261 min read

SpaceX: the hidden demand and the impact on the stock

DeepdivesSPCXJun 12, 20263 min read

SpaceX: pricing analysis and demand ahead of the IPO

DeepdivesSPCXJun 12, 20264 min read

COO continues to buy shares at weekly support price

PremiumInsidersMPJun 12, 20261 min read

SpaceX: the largest IPO in history opens for trading

BreakingSPCXJun 12, 20261 min read

Nasdaq updates on Nasdaq 100 rebalancing for June

Market OverviewQQQJun 12, 20261 min read

Dramatic news: markets surge amid progress with Iran

BreakingJun 11, 20261 min read

Option whales extremely bullish on NBIS stock

PremiumOption WhalesNBISJun 11, 20261 min read

President Trump announces cancellation of attacks and Iran's surrender

BreakingJun 11, 20261 min read

Ocular Therapeutix: Analyst raises price target to $10 per share

PremiumAnalystsOTLKJun 11, 20261 min read

SNDK rises 8%

PremiumBreakingSNDKJun 11, 20261 min read